Haemonetics Corporation (HAE)

Haemonetics Stock Forecast

Stock Price Forecast

The 9 analysts that cover Haemonetics stock have a consensus rating of "Strong Buy" and an average price target of $99.78, which forecasts a 38.45% increase in the stock price over the next year. The lowest target is $84 and the highest is $116.

Price Target: $99.78 (+38.45%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$84	$99.78	$100	$116
Change	+16.55%	+38.45%	+38.75%	+60.95%

* Price targets were last updated on May 20, 2025.

Analyst Ratings

The average analyst rating for Haemonetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	4	4	4	4	4	4
Buy	3	3	3	3	3	3
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Turkaly JMP Securities	JMP Securities	Buy Reiterates $100	Buy	Reiterates	$100	+38.75%	May 20, 2025
Andrew Cooper Raymond James	Raymond James	Strong Buy Reiterates $115 → $105	Strong Buy	Reiterates	$115 → $105	+45.69%	May 9, 2025
Mike Matson Needham	Needham	Strong Buy Maintains $104 → $84	Strong Buy	Maintains	$104 → $84	+16.55%	May 8, 2025
Mike Matson Needham	Needham	Strong Buy Maintains $108 → $104	Strong Buy	Maintains	$108 → $104	+44.30%	Mar 18, 2025
Andrew Cooper Raymond James	Raymond James	Strong Buy Reiterates $120 → $115	Strong Buy	Reiterates	$120 → $115	+59.57%	Feb 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.32B

Decreased by -2.71%

from 1.36B

Revenue Next Year

1.42B

Increased by 7.18%

from 1.32B

EPS This Year

4.92

Increased by 48.62%

from 3.31

EPS Next Year

5.69

Increased by 15.76%

from 4.92

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Apr 3, 2021	Apr 2, 2022	Apr 1, 2023	Mar 30, 2024	Mar 29, 2025	Mar 31, 2026	Mar 31, 2027	Mar 31, 2028
Revenue	870.46M	993.20M	1.17B	1.31B	1.36B	1.32B	1.42B	1.57B
Revenue Growth	-11.94%	14.10%	17.67%	12.01%	3.96%	-2.71%	7.18%	10.36%
EPS	1.55	0.84	2.24	2.29	3.31	4.92	5.69	6.37
EPS Growth	4.73%	-45.81%	166.67%	2.23%	44.54%	48.62%	15.76%	11.86%
Forward PE	-	-	-	-	-	14.65	12.66	11.31
No. Analysts	-	-	-	-	-	11	9	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	1.5B	1.5B	1.7B
Avg	1.3B	1.4B	1.6B
Low	1.3B	1.3B	1.5B

Revenue Growth

Revenue Growth	2026	2027	2028
High	7.5%	15.3%	19.5%
Avg	-2.7%	7.2%	10.4%
Low	-7.0%	1.9%	4.2%

EPS Forecast

EPS	2026	2027	2028
High	5.31	6.14	6.80
Avg	4.92	5.69	6.37
Low	4.71	5.29	5.90

EPS Growth

EPS Growth	2026	2027	2028
High	60.5%	24.9%	19.5%
Avg	48.6%	15.8%	11.9%
Low	42.3%	7.6%	3.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.